chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Itchiness under the chin; Redness due to scratching; Felt like a rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness under the chin), ERYTHEMA (Redness due to scratching) and RASH (Felt like a rash) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No relevant medical history was reported.  Concomitant products included MAGNESIUM and ZINC for Mineral supplementation, MULTIVITAMINS [VITAMINS NOS] for Vitamin A supplementation, VITAMIN D [VITAMIN D NOS] for Vitamin supplementation.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PRURITUS (Itchiness under the chin), ERYTHEMA (Redness due to scratching) and RASH (Felt like a rash). At the time of the report, PRURITUS (Itchiness under the chin), ERYTHEMA (Redness due to scratching) and RASH (Felt like a rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details provided as applied hydrocortisone cream.  Upon internal review on 20-May-21, the age was corrected 71 years   Reporter did not allow further contact
On 0126/2021-After 4 hours, left arm, became stiff in muscle down to wrist plus pain and ache upon movement plus itching from left armpit to stomach; subsided by 4pm; then next 4 days, patient awakened about 1:30 am to 2:30 am with constant pain in arm; took 2 Tylenol, lessened by 6 am. Then at 1:30 am 01/31/2021, flat in bed, awakened by a severe pain in both shoulders, arms, sides with movement of crushing sensation and weird feeling going down left side to belt line, crossing over and meeting at right side belt line; with crushing, paralyzed effect for about 30 minutes.  i felt like about ready to die. Tried arms and legs to work with some exercise, helped little.  Got up,for toilet to urinate, took 2 tylenol,
Rash, itchiness in the body, general feeling of weakness, fever, headaches, muscular aches.   Benadril 50 mg/ Decadron.   Home: Medrol 4mg/ Ataray 25mg.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 20-Dec-2021; Patient Received vaccine beyond Expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient Received vaccine beyond Expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 20-Dec-2021) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022 at 11:03 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022 at 11:03 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient Received vaccine beyond Expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 20-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient Received vaccine beyond Expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 20-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  No concomitant medication was reported by reporter. Vaccine was in thaw state (2 to 8 degree Celsius) from about 20-Dec-2021. Dose was given at 02-Apr-2022 11:03:53  No treatment medication was reported by reporter.
Patient woke-up up with a fever of 103.1.  She was shaking and was weak, dizzy, & a little pale.  She complained that her tongue was burning.  This was on the 1st of December.  I took her to the weekend doctor and had forgot that she had this vaccination, so did not inform them of it. They said they found nothing wrong with her, but again, I did not inform them of this vaccination, because I forgot that she had it. On Sunday, December 2nd, she was hoarse the whole day.  To my knowledge she is ok, but I will call to possibly set up another appointment, if they want to see her.  She had this vaccine done at her school.  They sent home a note with the vaccine information, but I cannot tell the name of the person who administered it.
patient's arm look very red on the inside part of itfrom shoulder to wrist. it was also warm as it was inflamed. patient was taking ibruprofen to bring down pain , swollen
h/a, blurry vision, very pale, blue lips, dizzy. Sweating, weak. EMS called and arrived (with parents)
Information has been received from a pharmacist via a company representative, referring to an unspecified number of patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, these patients were vaccinated with ZOSTAVAX (dose, strength, anatomical site, route and lot number were not reported). Subsequently, on unspecified dates, the patients developed unspecified injection site reaction and/or fever. At the time of this report, the outcome of the events and its casual relation with the vaccine were unknown. No product quality complaint was involved. Additional information has been requested.
Didn't feel a pinch but instead felt most of her dose roll down her arm and into her arm.; Did not receive second dose and would like to know if can retake it; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (Didn't feel a pinch but instead felt most of her dose roll down her arm and into her arm.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Did not receive second dose and would like to know if can retake it) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included LEVETIRACETAM, CALCIUM, BIOTIN, ESCITALOPRAM and ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION) for an unknown indication.    On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced UNDERDOSE (Didn't feel a pinch but instead felt most of her dose roll down her arm and into her arm.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Did not receive second dose and would like to know if can retake it). On 05-Feb-2021, UNDERDOSE (Didn't feel a pinch but instead felt most of her dose roll down her arm and into her arm.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Did not receive second dose and would like to know if can retake it) had resolved. Not Provided          Treatment information not provided.
Pt c/o fast heart beat and diaphoresis. Brought to med obs #1 via wheelchair. Pt reports improvement of symptoms upon arrival and positioned flat on stretcher. Pt offered water/snack, refused. VSS. No s/s of distress noted. Escorted to exit via staff.
Second dose of Covid-19 vaccine administered greater than 6 hours after vaccine was mixed; Second dose of Covid-19 vaccine administered greater than 6 hours after vaccine was mixed; Second dose of Covid-19 vaccine administered greater than 6 hours after vaccine was mixed; Sore arm; This is a spontaneous report from a contactable pharmacist via Pfizer sponsored program. This report has similar events for 3 patients. This is 2 of 3 reports  A 13-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE). 2nd dose. Formulation: solution for injection, Lot number EW0217) via an unspecified route of administration, on 09Jun2021, single dose (at the age of 13-years-old) for COVID-19 immunization. The patients medical history and concomitant medications were not reported. On 09Jun2021, the patient experienced product temperature excursion issue, poor quality vaccine administered, product preparation error and in Jun2021 the patient experienced pain in arm. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The clinical outcome of the events was unknown. Information on Lot/Batch number has been requested.  Follow up (14Jun2021): This is a follow up spontaneous report from a contactable pharmacist. This pharmacist reported for a 13-year-old male patient that: Duplicate AE E-transmitted for report of inadvertent dosing of the vaccine past 6 hour storage in syringe. Caller would like written document sent to email address. Caller states she has not received previous email request.  Response: Disclaimer Provided Pfizer has conducted physical and chemical stability studies which have shown that the vaccine maintains all its measured quality attributes when diluted vaccine is stored in polycarbonate or polypropylene syringes for 6 hours at 2 degree C to 30 degree C. Microbiological risk must be considered. Degradation of RNA in the vaccine has been observed when stored for longer than 6 hours in syringes.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021683146 same reporter, AE and product, different patient;US-PFIZER INC-2021684836 same reporter, AE and product, different patient
itching from the neck to the waist; shaking terribly; sinuses were so plugged that could hardly breathe; keeps falling down; fuzzy headed; terrible pain; Caller received the first dose of the Covid vaccine on 19MAR2021. On 27MAR2021, caller tested positive for the Covid virus; This is a spontaneous report from a contactable other HCP (patient). This other HCP reported for herself that a 74-years-old female patient received first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, batch/lot number: 3R2613; expiry date: unspecified), via an unspecified route of administration on 19Mar2021 as 0.3ML single dose for COVID-19 immunisation. The patient had neurological problems and has trouble with holding conversations and therefore writes things down. Concomitant medications were not reported. Caller received the first dose of the Covid vaccine on 19Mar2021. On 27Mar2021, the patient tested positive for the Covid virus and was presenting many symptoms. She would like to tell that she did not have problems in the lungs. After caller's Covid-19 diagnosis, she reports that she was "not in her right mind and her head felt like it was going to explode." She explains that she had itching from the neck to the waist, pain in the head, she was shaking terribly, her head was so bad with pain that she was coughing about bringing stuff up, the stuff coming up was tenacious and coloured stuff, the colour varied from clear to brown. Her head hurt and the temperature was elevated by 3 degrees, she seldom ever has a temperature. Her sinuses were so plugged that she could hardly breathe (her glands were so swollen that she has trouble swallowing), she was sneezing so bad having trouble breathing. She keeps falling down. She doesn't know what to do for the next vaccine, she wants to know when was it okay to get the second dose, she keeps falling down. She wants to know when it safe to get the vaccine. She was experiencing fuzzy headed and in terrible pain. She had diarrhoea, then vomiting that's why she can't take anything (including her medicines), now she was so shaky and falls and has trouble writing. The patient did not receive the second vaccine due to her illness and concern for becoming more ill. She had heard she must wait 30 days after having the Covid virus to receive the vaccine. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Developed large Hematoma that was red, hot and swollen @ injection site: to RLT the following afternoon after administration. Was given PO antibiotic and is doing well.
PT was a new employee at  Health and Rehab Center and consented to take the vaccine (Moderna).   PT received Dose 1 of Moderna on 07/29/2021.  Administrator was preparing for the 2nd dose to be given on 08/26/2021 when PT informed her that she already has had both doses and that she had her 1st dose at another facility.   Administrator asked for her to bring in the documentation so we could properly update our records of vaccinated employees.   On 08/20/2021 PT phoned Administrator and informed her that on 07/07/2021 she received the Johnson/Johnson vaccine, she thought she had received the Moderna.   At this time PT has not had any specific reaction from receiving 2 different vaccines.  With the new guideline for boosters we do not know where she will stand.
Given 0.5 mL dose instead of recommended 0.25 mL dose. 5-6 hours after receiving dose had headache, nausea and sore arm. Was wondering if could take Tylenol so came to the clinic for evaluation and it was noted pt was given 0.5 mL for her booster shot and pt is not immunocompromised. Patient having similar reaction to 2 other Moderna doses. Advised Tylenol as needed and follow up for any questions or concerns. Notified I would report incorrect dose to VAERs reporting system but patient otherwise doing well.
No adverse event; Pneumococcal received on 31-JUL-2014 and 14-SEP-2016; This spontaneous report was received from a 65-year-old female patient, concerning to herself. The patient's medical history, previous drug reactions or allergies and concomitant medications were not reported.      On 31-JUL-2014, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (reported as "pneumococcal") for prophylaxis. (strength, dose, route of administration, anatomical location, lot # and expiration date were not provided). On 14-SEP-2016, it was reported that another doses of pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (reported as pneumococcal") was administered (inappropriate schedule of product administration). No adverse event involved with vaccine reported.  This is one of two reports received from the same patient.; Sender's Comments:  US-009507513-2004USA006765:
Dose Administration Error (Invalid Dose); This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (Dose Administration Error (Invalid Dose)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Dose Administration Error (Invalid Dose)). At the time of the report, INCORRECT DOSE ADMINISTERED (Dose Administration Error (Invalid Dose)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant  medications reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-106726, US-MODERNATX, INC.-MOD-2021-106777, US-MODERNATX, INC.-MOD-2021-106851 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-106726:crosslinked US-MODERNATX, INC.-MOD-2021-106777:crosslinked US-MODERNATX, INC.-MOD-2021-106851:crosslinked
Patient stood up a few minutes after completion of vaccination to ask questions, and then said she felt nauseated and when she went to sit down lost balance, but did not completely lose consciousness. At this time she informed the vaccinating  pharmacist that she had not eaten anything all day and was quite anxious about the vaccinations. She requested the pharmacy call 911 and the paramedics arrived and left with the patient. Upon follow up call today by pharmacy manager (07/29/2020, the day after) patient stated she felt "perfectly fine" after she went home that day, and had no signs or symptoms.
Temp 102.4 (was probably higher, didn't take it until the next day), incredible body aches, weakness, headache, all these symptoms are continuing 3 days later except for temperature.  Had to call in sick to work.  If patient not better by tomorrow, will have to see the doctor.  NEVER would have gotten the flu vac if the educational information had included to wait 2 weeks after antibiotic completion.  Patient has been so adversely affected by this vaccine that they don't plan on ever taking the vaccine again and is warning other to beware!
I began having hemifacial spasms after my second vaccine that lasted for a couple of months. It was not often and seemed like it went away, so I thought it was stress. Following my third vaccine, I noticed it reoccurring within 24 hours when I started my fever and chills and it has gotten worse and stronger even though it has now been almost two weeks from my booster.
Headache fatigue, shortness of breath, chills. Narrative: reports less than a day after vaccination, developed severe joint pain (lessen over time, but not resolved), and intermittent headache, chills, fatigue, and SOB.
put on about 5lbs/all the weight's gone to my waist/130 to 135 lbs; This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT INCREASED (put on about 5lbs/all the weight's gone to my waist/130 to 135 lbs) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced WEIGHT INCREASED (put on about 5lbs/all the weight's gone to my waist/130 to 135 lbs). At the time of the report, WEIGHT INCREASED (put on about 5lbs/all the weight's gone to my waist/130 to 135 lbs) outcome was unknown.            No Concomitant medications were provided. No treatment medications were provided. The patient tried to cut down on what she's been eating recently.
Large red ring on arm, painful, warm to touch, migraine, vomited once, felt shaky.
sciatic pain; COVID-19; Sickness; This spontaneous case was reported by a consumer and describes the occurrence of SCIATICA (sciatic pain), COVID-19 (COVID-19) and ILLNESS (Sickness) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 4782590) for COVID-19 vaccination.    Co-suspect products included non-company products NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 and ADALIMUMAB (HUMIRA) for Crohn's disease.    No Medical History information was reported.   On 25-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Aug-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In 2021, the patient experienced ILLNESS (Sickness). On 30-Aug-2021, the patient experienced COVID-19 (COVID-19). On 19-Aug-2022, the patient experienced SCIATICA (sciatic pain). At the time of the report, SCIATICA (sciatic pain) had not resolved, COVID-19 (COVID-19) had resolved and ILLNESS (Sickness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  There was no reported medical history.  It was unknown if patient was enrolled in COVID-19-Vaccine Trial. On 2021-08-23, the patient experienced sciatic pain. On unknown date, sciatic pain recovered/resolved. The reporter's causality for the event(s) of covid-19, sciatic pain and sciatic pain with Adalimumab Solution for Injection was No Reasonable Possibility.  HUMIRA COVID-19, Non-Health Care Professional, Global Introspection, Not Related. HUMIRA Sciatica, Non-Health Care Professional, Global Introspection, Not Related  Agency's opinion was that the causality for the event(s) of covid-19, sciatic pain, sciatic pain and sick with paxlovid (nirmatrelvir;ritonavir) was not provided.  Agency's opinion was that the causality for the event(s) of covid-19, sciatic pain, sciatic pain and sick with adalimumab solution for injection was not provided  No treatment information was provided.
Blood pressure reached 238/121.  He went into the emergency room for testing.  At the time of release blood pressure dropped down to 197/100.
Vomit, fever, joint pain an lower back.  Muscle cramps, loss of appetite and tiredness.
severe abdominal pain; This case was reported by a consumer via call center representative and described the occurrence of abdominal pain in a 74-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced abdominal pain. On an unknown date, the outcome of the abdominal pain was not recovered/not resolved.   It was unknown if the reporter considered the abdominal pain to be related to Shingrix.  Additional information was provided as follows: The patient stated, it was reaction to the shot. The patient had to go to the emergency room. The patient wanted to put this in records for the side affect of these unsafe vaccines.
allergic reaction; He vomited; his face turns hot; coughing; trouble breathing; Face turned bright red; he was irritable/ Extremely irritable; upset stomach; stomach hard; This case was reported by a consumer via call center representative and described the occurrence of allergic reaction in a 9-month-old male patient who received HBV (Engerix B) for prophylaxis.   Concurrent medical conditions included vegetable allergy.   In April 2019, the patient received Engerix B. In April 2019, less than a day after receiving Engerix B, the patient experienced allergic reaction, vomiting, feeling of warmth facial, cough, difficulty breathing, upset stomach, gastric disorder, red face and irritability. On an unknown date, the outcome of the allergic reaction, vomiting, feeling of warmth facial, cough, difficulty breathing and red face were unknown and the outcome of the upset stomach, gastric disorder and irritability were recovered/resolved.   It was unknown if the reporter considered the allergic reaction, vomiting, feeling of warmth facial, cough, difficulty breathing, upset stomach, gastric disorder, red face and irritability to be related to Engerix B.  Additional details were provided as follows: The reporter's son had the shot last week visit and had an allergic reaction. The patient had a corn allergy so the reporter trying to narrow down what the ingredient was and believe it was called Engerix. The patient vomited 2 times in the office after his shot and his face turns hot and bright red like a sunburn. The reporter stated that at night he woke up with coughing, trouble breathing and then vomited again. In April 2019, less than a week after receiving Engerix B the patient was extremely irritable and upset stomach, Stomach hard for the next 3 days. This same reaction he had when he was exposed to corn. He was diagnosed with a corn allergy in Jan 2019. The patient pediatrician also did not believe that the patient was having a reaction, he just thought he was upset that had to have a shot.